# Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes

Study · id `cardio:ct-nct02787161` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02787161](<https://clinicaltrials.gov/study/NCT02787161>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02787161

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 195 participants.

## Technical summary

Registry record NCT02787161. Randomized; no masking; primary purpose treatment. Start 2016-08 (actual); primary completion 2018-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 195 participants (enrolled count; ClinicalTrials.gov record NCT02787161, source copy `cardio:ctgov-nct02787161-2019-09-16`, retrieved 2026-10-26)
- Started: 2016-08 (actual) (ClinicalTrials.gov record NCT02787161, source copy `cardio:ctgov-nct02787161-2019-09-16`, retrieved 2026-10-26)
- Primary completion: 2018-04 (actual) (ClinicalTrials.gov record NCT02787161, source copy `cardio:ctgov-nct02787161-2019-09-16`, retrieved 2026-10-26)
- Completion: 2018-09 (actual) (ClinicalTrials.gov record NCT02787161, source copy `cardio:ctgov-nct02787161-2019-09-16`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT02787161, source copy `cardio:ctgov-nct02787161-2019-09-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02787161-2019-09-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes
- Acronym: HDFIT
- Condition: Chronic Kidney Disease
- Intervention (Device): Hemodiafiltration
- Intervention (Device): Hemodialysis
- Lead sponsor: Pontifícia Universidade Católica do Paraná
- Lead sponsor class: OTHER
- Collaborator: Fresenius AG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of hemodialysis and post-dialysis period on granular activity levels (`cardio:pubmed-32450793`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial (`cardio:pubmed-35239175`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b982a48149ceebc705cca6f94bd2b42a70aa71ded0bd159d837424335676818c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
